Such an effort is represented by the Genome Cancer Atlas (TGCA), which has already ... particularly those with IDH1/IDH2mutation and 1p/19q codeletion, more vulnerable to treatment and therefore ...

证券时报e公司讯，艾德生物10月25日晚间公告，公司于近日获得由国家药监局颁发的人类IDH1基因突变检测试剂盒《中华人民共和国医疗器械注册证》。